National Arthritis Awareness Month News: All-Natural Flexcerin to the Rescue

Share Article

Sales of Vitaloix Labs' all-natural arthritis supplement - Flexcerin - are soaring in the second quarter--further spurred by the start of the month of May, which is National Arthritis Awareness Month.

Vitaloix Labs' - the makers of one of the top selling, all-natural arthritis supplements, Flexcerin - are seeing a huge surge in sales during the second quarter, as May marks National Arthritis Awareness Month.

In early May article that was published on Mlive.com that cited findings from the HudsonAlpha Institute (as well as interviewing the founder) - an institute that researches potential cures for arthritis - announced they are working on, "Groundbreaking research that could someday find a cure for Arthritis."

With May being National Arthritis Awareness month, there could not be better time for a more positive announcement to be unveiled. The article goes on to talk about why and how the institute was first created, as the founder, Jim Hudson, was diagnosed with arthritis when he was 28.

Hudson talks about his struggle with this disease in the article, stating, "Arthritis is the reason I'm here in the first place. I have suffered for 40 years. It changed my whole career as a foundry man and physicist to bio-technologist in order for me to work on my own disease."

The outlook for the institute and their fight against arthritis is looking pretty good too, according to the interview with Hudson. "At this point it looks like African Americans are 30% to 40% more prone to get Rheumatoid Arthritis than European decent. This study will clarify that and hopefully uncover new genes involved in rheumatoid arthritis."

The institute just secured future funding as well, as the article cites.

"Thanks to a 5-year, $4.4-million grant, researchers at HudsonAlpha, along with researchers at UAB are studying 2,000 people affected by arthritis and 2,000 controlled samples that are not affected. They will then analyze those genes over the next few years."

As far as a cure being in sight, according to the interview, Hudson is pretty positive, stating, "This idea of genome technology analysis applies to everything. For example, we can test if a drug works for you, but not for somebody else. It's so powerful and exciting to find new ways to apply it whether it be cancer or now arthritis."

The article concludes by summing up just how many people are affected by this disease.

"There are more than 100 forms of arthritis, including juvenile arthritis. In Michigan, there are more children with juvenile arthritis than juvenile diabetes and cerebral palsy combined, according to the Arthritis Foundation."

(Source: Internet, 2010; http://www.mlive.com/news/flint/index.ssf/2010/05/hundreds_march_for_arthritis_c.html.)

The spokesperson for Flexcerin, Contessa Jackson, asserts that it is milestones like this, and enthusiastic go-getters (such as Hudson) that really are the caveat in the finding of a potential cure for arthritis in the future. In the meanwhile, however, there are still ways for those who suffer from the ailments of this disease to seek fast, effective relief.

"We always get cheerful when reading articles about amazing people like Hudson and the revolutionary research that his institute is conducting, especially when such publications are made during National Arthritis Awareness Month," Jackson states.

With a cure somewhere in sight over the years to come, Jackson adds that in the meanwhile there are some natural treatment options for arthritis. "We developed the formula for Flexcerin with the sufferer, and all associated ailments in mind. For those who are seeking safe, natural and effective relief - and one that does not come with any side effects attached - our product offers them an affordable, botanical and nonprescription solution."

Flexcerin is able to treat the symptoms associated with arthritis by using a revolutionary, scientifically designed formula that is based upon years of research and clinical testing, which promotes healthy joint functions and works to alleviate pain and swelling, while repairing damaged joints.

The proprietary 'Maximum Strength Bone and Joint Formula' contained within Flexcerin was formulated to help rebuild worn joints, lubricate stiff joints, increase range of motion, improve mobility and flexibility, soothe inflamed joints and decrease pains associated with arthritis by rebuilding worn joints with Glucosamine, Chondroitin and MSM.

Flexcerin is also able to ease the aches and pains associated with arthritis by lubricating stiff joints with Omega 3 oils and other essential fatty acids, and by soothing aching, inflamed joints with special inflammation-inhibiting herbs (natural COX-2 inhibitors).

Most people will see and feel noticeable results from taking Flexcerin within one or two months of daily usage, when used as directed.

Learn more by visiting: http://www.Flexcerin.com

About Flexcerin:

  • Developed by Vitaloix Labs--a leading nutraceutical company
  • Contains a scientifically designed formula that is based upon years of research and clinical testing, which promotes healthy joint function and helps alleviate pain and swelling, and repairs damaged joints
  • The proprietary 'Maximum Strength Bone and Joint Formula' contained within Flexcerin was formulated to help rebuild worn joints, lubricate stiff joints, increase range of motion, improve mobility and flexibility, soothe inflamed joints and decrease pains associated with arthritis
  • Rebuilds worn joints with Glucosamine, Chondroitin and MSM
  • Lubricates stiff joints with Omega 3 oils and other essential fatty acids
  • Soothes aching, inflamed joints with special inflammation-inhibiting herbs (natural COX-2 inhibitors)
  • 100% safe, effective and all-natural
  • Available over-the-counter, no doctor prescription is required
  • Has no known, adverse side effects
  • Currently available at their secured online store, with a generous discount off the retail price when ordered online at: http://www.Flexcerin.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Liz Gilman
Visit website